Medicare Enrolled
Dr. Woondong Jeong, MD
Hematology & Oncology · Tomball, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Jeong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jeong?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jeong
Dr. Woondong Jeong is a hematology & oncology specialist in Tomball, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Jeong performed 44,843 Medicare services across 836 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jeong received a total of $24,542 from 97 pharmaceutical and/or device companies across 1319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jeong is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in TX
$24,542 industry payments
Medicare Practice Summary
Medicare Utilization ↗44,843
Medicare services
Top 21% in TX for hematology & oncology
836
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,360 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
32,250 | $1 | $3 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
5,700 | $0 | $0 |
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $54 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,448 | $0 | $0 |
| Anti-nausea injection (ondansetron/Zofran) | 888 | $0 | $0 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
477 | $19 | $61 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
380 | $22 | $82 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
316 | $95 | $345 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
190 | $22 | $80 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
177 | $101 | $376 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
138 | $11 | $38 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $66 | $245 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
103 | $49 | $179 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
76 | $50 | $183 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
71 | $1 | $3 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
58 | $133 | $504 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
57 | $3 | $11 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
51 | $53 | $449 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
51 | $95 | $285 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
45 | $182 | $833 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
36 | $133 | $452 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
29 | $76 | $303 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
27 | $127 | $473 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
26 | $1,180 | $5,692 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 25 | $110 | $295 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $102 | $361 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
19 | $53 | $187 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
17 | $143 | $480 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
12 | $17 | $61 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
73.6% high complexity
23.8% medium
2.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,542
Total received (2018-2024)
Avg $3,506/year across 7 years
Top 19% in TX for hematology & oncology
97
Companies
1,319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,206 (94.6%)
Other
Charitable contributions, space rental, and other categories
$678 (2.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$659 (2.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,909
2023
$4,103
2022
$4,429
2021
$3,528
2020
$2,750
2019
$3,304
2018
$2,519
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$2,465
E.R. Squibb & Sons, L.L.C.
$1,427
PFIZER INC.
$1,367
Janssen Biotech, Inc.
$1,189
Amgen Inc.
$1,061
AstraZeneca Pharmaceuticals LP
$989
Merck Sharp & Dohme Corporation
$972
GlaxoSmithKline, LLC.
$893
GENZYME CORPORATION
$883
Celgene Corporation
$836
Astellas Pharma US Inc
$685
Daiichi Sankyo Inc.
$628
Eisai Inc.
$596
Seagen Inc.
$559
Incyte Corporation
$545
Lilly USA, LLC
$536
Genentech USA, Inc.
$520
Takeda Pharmaceuticals U.S.A., Inc.
$439
Gilead Sciences, Inc.
$411
Merck Sharp & Dohme LLC
$410
Karyopharm Therapeutics Inc.
$348
Pharmacyclics LLC, An AbbVie Company
$335
Bayer HealthCare Pharmaceuticals Inc.
$295
ABBVIE INC.
$269
Janssen Pharmaceuticals, Inc
$229
Kite Pharma, Inc.
$207
TerSera Therapeutics LLC
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$197
JAZZ PHARMACEUTICALS INC.
$192
Rigel Pharmaceuticals, Inc.
$187
NOVARTIS PHARMACEUTICALS CORPORATION
$185
EISAI INC.
$175
Teva Pharmaceuticals USA, Inc.
$156
Puma Biotechnology, Inc.
$155
Agios Pharmaceuticals, Inc.
$152
Blueprint Medicines Corporation
$149
AVEO Pharmaceuticals, Inc.
$147
MorphoSys, US Inc.
$141
Regeneron Healthcare Solutions, Inc.
$133
Mirati Therapeutics, Inc.
$130
PUMA BIOTECHNOLOGY, INC.
$126
Adaptive Biotechnologies Corporation
$126
Ipsen Biopharmaceuticals, Inc
$120
EMD Serono, Inc.
$119
Deciphera Pharmaceuticals Inc.
$119
PharmaEssentia USA Corporation
$117
Exelixis Inc.
$114
Pharmacyclics LLC, an AbbVie Company
$96
SpringWorks Therapeutics, Inc.
$95
ARRAY BIOPHARMA INC
$90
BeiGene USA, Inc.
$88
Dendreon Pharmaceuticals LLC
$85
TAIHO ONCOLOGY, INC.
$83
Boston Scientific Corporation
$79
Seattle Genetics, Inc.
$79
Coherus Biosciences Inc.
$78
Dova Pharmaceuticals
$77
Taiho Oncology, Inc.
$74
Kyowa Kirin, Inc.
$73
CTI BioPharma Corp.
$71
Stemline Therapeutics Inc.
$68
Foundation Medicine, Inc.
$67
Nestle HealthCare Nutrition Inc.
$67
Myovant Sciences Inc.
$66
Bayer Healthcare Pharmaceuticals Inc.
$60
Tempus AI, Inc
$60
Pharming Healthcare, Inc.
$58
TESARO, Inc.
$56
MEDIVATION FIELD SOLUTIONS LLC
$53
SERVIER PHARMACEUTICALS LLC
$45
SANOFI-AVENTIS U.S. LLC
$42
G1 Therapeutics, Inc.
$38
ADC Therapeutics America, Inc.
$38
Sandoz Inc.
$36
Spectrum Pharmaceuticals Inc.
$35
Mylan Institutional Inc.
$30
SUN PHARMACEUTICAL INDUSTRIES INC.
$30
Tactile Systems Technology Inc
$30
Pharmacosmos Therapeutics Inc.
$29
AMAG Pharmaceuticals, Inc.
$27
Blue Earth Diagnostics Limited
$26
Alnylam Pharmaceuticals Inc.
$26
SOBI, INC
$22
Servier Pharmaceuticals LLC
$22
Sumitomo Pharma America, Inc.
$20
Acceleron Pharma, Inc.
$19
AbbVie Inc.
$19
Midatech Pharma US Inc
$18
Amneal Pharmaceuticals LLC
$17
AbbVie, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$17
Clovis Oncology, Inc.
$14
Fortovia Therapeutics, Inc.
$14
Global Blood Therapeutics, Inc.
$14
Secura Bio, Inc.
$14
Sun Pharmaceutical Industries Inc.
$13
Otsuka America Pharmaceutical, Inc.
$12
Top 3 companies account for 21.4% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVASTIN · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · Axumin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · COSELA · CYRAMZA · Cabometyx · Columvi · Creon · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Erleada · FERAHEME · FLEXITOUCH · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Flexitouch Plus · GAVRETO · GAZYVA · GILOTRIF · Gelclair · HYQVIA · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · Inrebic · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · Monoferric · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · OXLUMO · Odomzo · Ogivri · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROLVEDON · RUCONEST · RYBREVANT · RYDAPT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · Truxima · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZARXIO · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $55 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
43
Per 100K population
0.9
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE TOMBALL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jeong is a mixed practice specialist, with above-average Medicare volume (top 21% in TX), with low-engagement industry engagement in the top 19% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jeong experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Jeong performed 32,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jeong receive payments from pharmaceutical companies?
Yes. Dr. Jeong received a total of $24,542 from 97 companies across 1,319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jeong's costs compare to other hematology & oncology specialists in Tomball?
Dr. Jeong's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jeong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Tomball
Browse hematology & oncology specialists in Tomball ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology